314 related articles for article (PubMed ID: 16240002)
1. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system.
Wipf P; Lynch SM; Powis G; Birmingham A; Englund EE
Org Biomol Chem; 2005 Nov; 3(21):3880-2. PubMed ID: 16240002
[TBL] [Abstract][Full Text] [Related]
2. Natural product based inhibitors of the thioredoxin-thioredoxin reductase system.
Wipf P; Lynch SM; Birmingham A; Tamayo G; Jiménez A; Campos N; Powis G
Org Biomol Chem; 2004 Jun; 2(11):1651-8. PubMed ID: 15162219
[TBL] [Abstract][Full Text] [Related]
3. New inhibitors of the thioredoxin-thioredoxin reductase system based on a naphthoquinone spiroketal natural product lead.
Wipf P; Hopkins TD; Jung JK; Rodriguez S; Birmingham A; Southwick EC; Lazo JS; Powis G
Bioorg Med Chem Lett; 2001 Oct; 11(19):2637-41. PubMed ID: 11551767
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.
Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ
Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491
[TBL] [Abstract][Full Text] [Related]
5. Synthetic and biological studies on the spiro-mamakone system.
Murphy AC; Devenish SR; Muscroft-Taylor AC; Blunt JW; Munro MH
Org Biomol Chem; 2008 Oct; 6(20):3854-62. PubMed ID: 18843418
[TBL] [Abstract][Full Text] [Related]
6. Parallel syntheses of disulfide inhibitors of the thioredoxin redox system as potential antitumor agents.
Kirkpatrick DL; Watson S; Kunkel M; Fletcher S; Ulhaq S; Powis G
Anticancer Drug Des; 1999 Oct; 14(5):421-32. PubMed ID: 10766297
[TBL] [Abstract][Full Text] [Related]
7. Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase.
Powis G; Wipf P; Lynch SM; Birmingham A; Kirkpatrick DL
Mol Cancer Ther; 2006 Mar; 5(3):630-6. PubMed ID: 16546977
[TBL] [Abstract][Full Text] [Related]
8. Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth.
McNaughton M; Engman L; Birmingham A; Powis G; Cotgreave IA
J Med Chem; 2004 Jan; 47(1):233-9. PubMed ID: 14695837
[TBL] [Abstract][Full Text] [Related]
9. Studies toward novel peptidomimetic inhibitors of thioredoxin-thioredoxin reductase system.
Kłossowski S; Muchowicz A; Firczuk M; Swiech M; Redzej A; Golab J; Ostaszewski R
J Med Chem; 2012 Jan; 55(1):55-67. PubMed ID: 22128876
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors.
Millet R; Urig S; Jacob J; Amtmann E; Moulinoux JP; Gromer S; Becker K; Davioud-Charvet E
J Med Chem; 2005 Nov; 48(22):7024-39. PubMed ID: 16250662
[TBL] [Abstract][Full Text] [Related]
11. Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs.
Kunkel MW; Kirkpatrick DL; Johnson JI; Powis G
Anticancer Drug Des; 1997 Dec; 12(8):659-70. PubMed ID: 9448705
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs.
Wu W; Borch RF
Mol Pharm; 2006; 3(4):451-6. PubMed ID: 16889439
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new 4beta-anilino- and 4beta-imido-substituted podophyllotoxin congeners.
Kamal A; Gayatri NL; Reddy DR; Mohan Reddy PS; Arifuddin M; Dastidar SG; Kondapi AK; Rajkumar M
Bioorg Med Chem; 2005 Nov; 13(22):6218-25. PubMed ID: 16061385
[TBL] [Abstract][Full Text] [Related]
14. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G
Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
[TBL] [Abstract][Full Text] [Related]
15. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
Wang Y; Xin D; Liu K; Zhu M; Xiang J
Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vivo antitumor evaluation of 2-methoxyestradiol 3-phosphate, 17-phosphate, and 3,17-diphosphate.
Edsall AB; Agoston GE; Treston AM; Plum SM; McClanahan RH; Lu TS; Song W; Cushman M
J Med Chem; 2007 Dec; 50(26):6700-5. PubMed ID: 18052315
[TBL] [Abstract][Full Text] [Related]
17. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
[TBL] [Abstract][Full Text] [Related]
18. Antitumour properties of fluorinated benzothiazole-substituted hydroxycyclohexa-2,5-dienones ('quinols').
Lion CJ; Matthews CS; Wells G; Bradshaw TD; Stevens MF; Westwell AD
Bioorg Med Chem Lett; 2006 Oct; 16(19):5005-8. PubMed ID: 16908135
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and antitumor activity of new bis-aminomethylnaphthalenes.
Bollini M; Casal JJ; Bruno AM
Bioorg Med Chem; 2008 Sep; 16(17):8003-10. PubMed ID: 18715786
[TBL] [Abstract][Full Text] [Related]
20. In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs.
Radi M; Adema AD; Daft JR; Cho JH; Hoebe EK; Alexander LE; Peters GJ; Chu CK
J Med Chem; 2007 May; 50(9):2249-53. PubMed ID: 17419604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
